MannKind Corporation (MNKD)
NASDAQ·Healthcare·Biotechnology
$3.75
-1.19%
Mkt Cap $1.33B
Analyst Ratings
Buy
7
Hold
0
Sell
0
Price Target (12 analysts)
$8.50
Range $6.00 – $11.00
Implied Upside
+127.0%
Consensus $8.50 vs current $3.75
NASDAQ·Healthcare·Biotechnology
$3.75
-1.19%
Mkt Cap $1.33B
Buy
7
Hold
0
Sell
0
Price Target (12 analysts)
$8.50
Range $6.00 – $11.00
+127.0%
Consensus $8.50 vs current $3.75